Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma

Peto, 1999, The European mesothelioma epidemic., Br J Cancer, 79, 666, 10.1038/sj.bjc.6690105

Sugarbaker, 1999, Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients., J Thorac Cardiovasc Surg, 117, 54, 10.1016/S0022-5223(99)70469-1

Sugarbaker, 2004, Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies., J Thorac Cardiovasc Surg, 128, 138, 10.1016/j.jtcvs.2004.02.021

Baldini, 2004, External beam radiation therapy for the treatment of pleural mesothelioma., Thorac Surg Clin, 14, 543, 10.1016/S1547-4127(04)00108-2

Antman, 1988, Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965–1985., J Clin Oncol, 6, 147, 10.1200/JCO.1988.6.1.147

Vogelzang, 2003, Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma., J Clin Oncol, 21, 2636, 10.1200/JCO.2003.11.136

Giaccone, 2002, Phase II trial of ZD0473 as second-line therapy in mesothelioma., Eur J Cancer, 38, S19, 10.1016/S0959-8049(02)80018-1

Porta, 2005, Raltitrexed-oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients., Lung Cancer, 48, 429, 10.1016/j.lungcan.2004.11.015

Fizazi, 2003, Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study., J Clin Oncol, 21, 349, 10.1200/JCO.2003.05.123

Fennell, 2007, Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma., Cancer, 109, 93, 10.1002/cncr.22366

Vogelzang, 1999, Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma?, J Clin Oncol, 17, 2626

Sørensen, 2007, Pemetrexed as second-line treatment in malignant pleural mesothelioma after platinum-based first-line treatment., J Thorac Oncol, 2, 147, 10.1097/JTO.0b013e31802f3813

Jassem, 2008, Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma., J Clin Oncol, 26, 5139, 10.1200/JCO.2006.09.9887

Rusch, 2003, Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?, J Clin Oncol, 21, 2636, 10.1200/JCO.2003.02.043

Favaretto, 2003, Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma., Cancer, 97, 2791, 10.1002/cncr.11405

Mbidde, 1986, Phase II trial of carboplatin in the treatment of patients with malignant pleural mesothelioma., Br J Cancer, 54, 215

Vorobiof, 2002, Malignant pleural mesothelioma: a phase II trial with docetaxel., Ann Oncol, 13, 412, 10.1093/annonc/mdf046

Belani, 2004, Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology Group., Clin Lung Cancer, 6, 43, 10.3816/CLC.2004.n.020

Kindler, 2002, The role of gemcitabine in the treatment of malignant mesothelioma., Semin Oncol, 29, 70, 10.1053/sonc.2002.30232

van Meerbeeck, 1999, A Phase II study of gemcitabine in patients with malignant pleural mesothelioma., Cancer, 85, 2577, 10.1002/(SICI)1097-0142(19990615)85:12<2577::AID-CNCR13>3.0.CO;2-S

Byrne, 1999, Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study., J Clin Oncol, 17, 25, 10.1200/JCO.1999.17.1.25

Nowak, 2002, Multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma., Br J Cancer, 87, 491, 10.1038/sj.bjc.6600505

van Haarst, 2002, Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma., B J Cancer, 86, 342, 10.1038/sj.bjc.6600118

Favaretto, 2003, Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma., Cancer, 97, 2791, 10.1002/cncr.11405

Manegold, 2005, Second line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma., Ann Oncol, 16, 923, 10.1093/annonc/mdi187

Syrigos, 2005, Bi-weekly administration of docetaxel and gemcitabine as first-line therapy for non-small cell lung cancer: a phase II study., Anticancer Res, 25, 3489

Syrigos, 2007, Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: a phase II study., J Chemother, 19, 438, 10.1179/joc.2007.19.4.438

Karapanagiotou, 2008, A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer., Med Oncol, 25, 303, 10.1007/s12032-007-9036-9

Georgoulias, 2008, Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial., Lung Cancer, 59, 57, 10.1016/j.lungcan.2007.07.021

Syrigos, 2007, Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study., Anticancer Res, 27, 2887

Georgoulias, 2005, Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial., J Clin Oncol, 23, 2937, 10.1200/JCO.2005.04.016

Kosmidis, 2008, Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group., Ann Oncol, 19, 115, 10.1093/annonc/mdm430

Kosmas, 2007, A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens., Cancer Chemother Pharmacol, 59, 51, 10.1007/s00280-006-0242-5

Georgoulias, 2004, Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study., Br J Cancer, 91, 482, 10.1038/sj.bjc.6602010

Kosmidis, 2007, Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group., J Thorac Oncol, 2, 135, 10.1016/S1556-0864(15)30041-1

Ralli, 2009, Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study., Anticancer Res, 29, 3441

Jänne, 2006, Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program., J Thorac Oncol, 1, 506, 10.1097/01243894-200607000-00002

Serke, 2006, Second line chemotherapy in malignant pleural mesothelioma with oxaliplatin/gemcitabine [abstract]., Ann Oncol, 17, 231a

Zucali, 2008, Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma., Cancer, 112, 1555, 10.1002/cncr.23337